SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016366
Filing Date
2018-11-16
Accepted
2018-11-16 16:45:57
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 735035
2 ex10-1.htm EX-10.1 190941
3 ex31-1.htm EX-31.1 19828
4 ex31-2.htm EX-31.2 18056
5 ex32-1.htm EX-32.1 7481
6 ex32-2.htm EX-32.2 7552
7 ex2-1_001.jpg GRAPHIC 2434
  Complete submission text file 0001493152-18-016366.txt   5593721

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE rspi-20180930.xml EX-101.INS 1023415
9 XBRL SCHEMA FILE rspi-20180930.xsd EX-101.SCH 69111
10 XBRL CALCULATION FILE rspi-20180930_cal.xml EX-101.CAL 41584
11 XBRL DEFINITION FILE rspi-20180930_def.xml EX-101.DEF 268914
12 XBRL LABEL FILE rspi-20180930_lab.xml EX-101.LAB 445800
13 XBRL PRESENTATION FILE rspi-20180930_pre.xml EX-101.PRE 336203
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 181190320
SIC: 2834 Pharmaceutical Preparations